Genscript Biotech Corporation (1548.HK)

HKD 9.95

(0.2%)

Total Debt Summary of Genscript Biotech Corporation

  • Genscript Biotech Corporation's latest annual total debt in 2023 was 416.99 Million USD , up 19.21% from previous year.
  • Genscript Biotech Corporation's latest quarterly total debt in 2024 Q2 was 877.17 Million USD , up 137.23% from previous quarter.
  • Genscript Biotech Corporation reported annual total debt of 349.79 Million USD in 2022, up 123.59% from previous year.
  • Genscript Biotech Corporation reported annual total debt of 156.45 Million USD in 2021, up 184.44% from previous year.
  • Genscript Biotech Corporation reported quarterly total debt of 416.99 Million USD for 2023 FY, up 19.21% from previous quarter.
  • Genscript Biotech Corporation reported quarterly total debt of 416.99 Million USD for 2023 Q4, up 9.48% from previous quarter.

Annual Total Debt Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Total Debt of Genscript Biotech Corporation (2023 - 2013)

Year Total Debt Total Debt Growth
2023 416.99 Million USD 19.21%
2022 349.79 Million USD 123.59%
2021 156.45 Million USD 184.44%
2020 55 Million USD 127.92%
2019 24.13 Million USD 129.79%
2018 10.5 Million USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 8.17 Million USD 10.58%
2013 7.39 Million USD 0.0%

Peer Total Debt Comparison of Genscript Biotech Corporation

Name Total Debt Total Debt Difference
Uni-Bio Science Group Limited 52.86 Million HKD -688.753%
CK Life Sciences Int'l., (Holdings) Inc. 5.93 Billion HKD 92.969%